Adolor Corporation to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
August 11 2011 - 4:01PM
Business Wire
Adolor Corporation (NasdaqGM: ADLR) today announced that
management will present at the Wedbush Securities 2011 Life
Sciences Management Access Conference on Tuesday, August 16, 2011,
at 1:15 P.M. Eastern Daylight Time. The conference is being held at
the Le Parker Meridien, New York, NY.
Adolor’s presentation will be webcast live on the investor
relations section of the Company’s website and will be archived for
one week following the broadcast. To access the webcast, log onto
the Company’s website at www.adolor.com and click on “Investor
Insights,” then “Webcast.” Click on the link and follow the prompts
for registration and access.
About Adolor
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain and pain management products.
Adolor’s first approved product in the United States is ENTEREG®
(alvimopan), which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
E.A.S.E.® Program. For more information on ENTEREG, including its
full prescribing information, visit www.ENTEREG.com. The Company
currently co-promotes ENTEREG in collaboration with GSK.
The Company's lead development program compound is ADL5945, a
novel mu opioid receptor antagonist being developed for chronic OIC
that demonstrated statistically significant and clinically relevant
efficacy in Phase 2 trials. The Company also has several
earlier-stage compounds under development for the management of
pain and CNS disorders.
For more information, visit www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024